Total homocysteine and cardiovascular disease (Q33785883)

29 July 2017

1 reference

title

Total homocysteine and cardiovascular disease (English)

1 reference

29 July 2017

main subject

cardiovascular disease

1 reference

Refsum H

1 reference

29 July 2017

Ueland PM

1 reference

29 July 2017

Vollset SE

1 reference

29 July 2017

Nygård O

1 reference

29 July 2017

Brattström L

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Journal of Internal Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

246

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

425-454

1 reference

The identification of homocystine in the urine

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Metabolic Abnormalities Detected in a Survey of Mentally Backward Individuals in Northern Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

HOMOCYSTINURIA. STUDIES OF 20 FAMILIES WITH 38 AFFECTED MEMBERS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The pathogenesis of coronary artery disease. A possible role for methionine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Homocysteine and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Disorders of homocysteine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

S-adenosylmethionine synthesis: molecular mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Betaine–Homocysteine Methyltransferase Expression in Porcine and Human Tissues and Chromosomal Localization of the Human Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Methionine metabolism in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Protein-Bound Homocyst(e)ine in Normal Subjects and in Patients with Homocystinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The effect of blood sample aging and food consumption on plasma total homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

HOMOCYSTINURIA: METABOLIC STUDIES ON 3 PATIENTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Detection of heterozygotes for homocystinuria. Study of sulphur-containing amino acids in plasma and urine after L-methionine loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Analysis of CBS alleles in Czech and Slovak patients with homocystinuria: Report on three novel mutations E176K, W409X and 1223 + 37 de199

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Methionine loading test is necessary for detection of hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

HOMOCYSTINURIA: CLINICAL AND PATHOLOGICAL REVIEW OF TEN CASES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

PATHOLOGICAL FINDINGS IN HOMOCYSTINURIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

HOMOCYSTINURIA: AN ENZYMATIC DEFECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Molecular genetics of methylenetetrahydrofolate reductase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Human cystathionine beta-synthase cDNA: sequence, alternative splicing and expression in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Human methionine synthase. cDNA cloning, gene localization, and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Homocysteine response to methionine challenge in four obligate heterozygotes for homocystinuria and relationship with cystathionine beta-synthase mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Down's syndrome: an atheroma-free model?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Critical points for determining moderate hyperhomocyst(e)inaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Ethnic immunity to coronary heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Characterization of homocysteine metabolism in the rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

No net renal extraction of homocysteine in fasting humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Betaine, ethanol, and the liver: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Clinical significance of pharmacological modulation of homocysteine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Does metformin increase the serum total homocysteine level in non-insulin-dependent diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The effect of a subnormal vitamin B-6 status on homocysteine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Azaribine-homocystinemia-thrombosis in historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Effects of sub-50 oral contraceptives on homocysteine metabolism: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Accelerated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The effect of D-penicillamine on protein-bound homocyst(e)ine in homocystinurics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Psoriasis and occlusive vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Folic acid--an innocuous means to reduce plasma homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Association of mild hyperhomocysteinemia with cardiac graft vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Plasma homocysteine in the acute and convalescent phases after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Plasma homocysteine and menopausal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50--effect of smoking and extent of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Thyroid hormone and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

A Common Mutation in the Methylenetetrahydrofolate Reductase Gene (C677T) Increases the Risk for Deep-Vein Thrombosis in Patients With Mutant Factor V (Factor V:Q 506 )

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Prevalence of familial mild hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Vascular endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

New Concepts in Coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Hyperhomocyst(e)inemia Is a Risk Factor for Arterial Endothelial Dysfunction in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Arterial endothelial barrier dysfunction: actions of homocysteine and the hypoxanthine-xanthine oxidase free radical generating system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The cell-damaging effects of low amounts of homocysteine and copper ions in human cell line cultures are caused by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The oxidant stress of hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The role of oxidized lipoproteins in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Lipid peroxidation induced in vivo by hyperhomocysteinaemia in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Homocysteine as a modulator of platelet‐derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Platelet survival and morphology in homocystinuria due to cystathionine synthase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Activation of Hageman Factor by L-Homocystine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Prospective Study of Hyperhomocysteinemia as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Folate nutrition and older adults: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Fruit and vegetables, and cardiovascular disease: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The natural history of vascular disease in homocystinuria and the effects of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Hyperhomocysteinemia in premature arterial disease: examination of cystathionine beta-synthase alleles at the molecular level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

The VITA Project: C677T mutation in the methylene‐tetrahydrofolate reductase gene and risk of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

A Common Polymorphism in the Methylenetetrahydrofolate Reductase Gene, Homocysteine, and Ischemic Cerebrovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and the risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

A methylenetetrahydrofolate reductase gene polymorphism in ischaemic stroke and in carotid artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Folate and Vitamin B 6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Association between elevated plasma total homocysteine and increased common carotid artery wall thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

Methylenetetrahydrofolate reductase gene polymorphism Relation to blood pressure and cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1999.00512.X

10.1046/J.1365-2796.1999.00512.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference